Synthesis and structure—activity relationships of cyclopropane-containing analogs of pharmacologically active compounds


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The review summarizes information on cyclopropane as an independent pharmacophore group and as a fragment for modification of pharmacological activity level of medicines used in practice. The advantages of a cyclopropane fragment over its bioisosteres are that, on the one hand, this fragment imposes conformational rigidity on the molecules of physiologically active compounds and, on the other hand, the replacement of acyclic terminal and “linker” groups with a cyclopropane fragment increases the metabolic stability of the target structures and extends the scope of their therapeutic action.

Sobre autores

I. Novakov

Volgograd State Technical University

Email: maxim.nawrozkij@gmail.com
Rússia, 28 prosp. im. Lenina, Volgograd, 400131

A. Babushkin

Volgograd State Technical University

Email: maxim.nawrozkij@gmail.com
Rússia, 28 prosp. im. Lenina, Volgograd, 400131

A. Yablokov

Volgograd State Technical University

Email: maxim.nawrozkij@gmail.com
Rússia, 28 prosp. im. Lenina, Volgograd, 400131

M. Nawrozkij

Volgograd State Technical University

Autor responsável pela correspondência
Email: maxim.nawrozkij@gmail.com
Rússia, 28 prosp. im. Lenina, Volgograd, 400131

O. Vostrikova

Volgograd State Technical University

Email: maxim.nawrozkij@gmail.com
Rússia, 28 prosp. im. Lenina, Volgograd, 400131

D. Shejkin

Volgograd State Technical University

Email: maxim.nawrozkij@gmail.com
Rússia, 28 prosp. im. Lenina, Volgograd, 400131

A. Mkrtchyan

Volgograd State Technical University

Email: maxim.nawrozkij@gmail.com
Rússia, 28 prosp. im. Lenina, Volgograd, 400131

K. Balakin

Kazan Federal University, Education and Research Center of Pharmacy; I. M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenov University)

Email: maxim.nawrozkij@gmail.com
Rússia, 18 ul. Kremlevskaya, Kazan, 420008; Build. 2, 8 ul. Trubetskaya, Moscow, 119991


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies